Neural stem cells and transplantation studies in Parkinson's disease

Advances in Experimental Medicine and Biology

Volumn 741, Issue , 2012, Pages 206-216

  Pardal, Ricardo ^a   López Barneo, José ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT STEM CELL; ANIMAL BEHAVIOR; ARTICLE; CENTRAL NERVOUS SYSTEM FUNCTION; DOPAMINERGIC NERVE CELL; EXPERIMENTAL MODEL; HUMAN; INTRACELLULAR SIGNALING; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OUTCOME ASSESSMENT; PARKINSON DISEASE; PRIORITY JOURNAL; STEM CELL GENE THERAPY; STEM CELL NICHE; SUBVENTRICULAR ZONE; THERAPY EFFECT; TISSUE SPECIFICITY;

ADULT; ANIMALS; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; DOPAMINERGIC NEURONS; HUMANS; NERVOUS SYSTEM; NEURAL STEM CELLS; PARKINSON DISEASE; STEM CELL NICHE; STEM CELL TRANSPLANTATION;

ANIMALIA;

EID: 84859789501     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-2098-9_14     Document Type: Article

References (57)

1. Freed CR, Greene PE, Breeze RE et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. New Engl J Med 2001; 344:710-719. (Pubitemid 32204988)
2. Olanow CW, Goetz CG, Kordower JH et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 2003; 54:403-414. (Pubitemid 37072046)
3. Kriks S, Studer L. Protocols for generating ES cell-derived dopamine neurons. Adv Exp Med Biol 2009; 651:101-111.
4. Minguez-Castellanos A, Escamilla-Sevilla F. Cell therapy and other neuroregenerative strategies in Parkinson's disease (I and II). Rev Neurologia 2005; 41:604-614, 684-693. (Pubitemid 47282243)
5. Lindvall O, Kokaia Z, Martinez-Serrano A. Stem cell therapy for human neurodegenerative disorders-how to make it work. Nat Med 2004; 10 Suppl:S42-S50. (Pubitemid 38901866)
6. Freed CR. Will embryonic stem cells be a useful source of dopamine neurons for transplant into patients with Parkinson's disease? P Natl Acad Sci U S A 2002; 99:1755-1757. (Pubitemid 34168962)
7. Snyder BJ, Olanow CW. Stem cell treatment for Parkinson's disease: An update for 2005. Curr Opin Neurol 2005; 18:376-385. (Pubitemid 41104799)
8. Altman J. Are new neurons formed in the brains of adult mammals? Science 1962; 135:1127-1128.
9. Eriksson PS, Perfilieva E, Bjork-Eriksson T et al. Neurogenesis in the aduh humm hippocampus. Nat Med 1998; 4:1313-1317.
10. Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992; 255:1707-1710.
11. Kintner C. Neurogenesis in embryos and in adult neural stem cells. J Neurosci 2001; 22:639-643.
12. Doe CQ. Neural stem cells: Balancing self-renewal with differentiation. Development 2008; 135:1575-1587. (Pubitemid 351895487)
13. Falk A, Frisen J. New neurons in old brains. Ann Med 2005; 37:480-486. (Pubitemid 41693578)
14. Zhao C, Deng W, Gage FH. Mechanisms and functional implications of adult neurogenesis. Cell 2008; 132:645-660. (Pubitemid 351253687)
15. Rietze RL, Reynolds BA. Neural stem cell isolation and characterization. Methods Enzymol 2006; 419:3-23. (Pubitemid 44820360)
16. Molofsky AV, Pardal R, Morrison SJ. Diverse mechanisms regulate stem cell self-renewal. Curr Opin Cell Biol 2004; 16:700-707. (Pubitemid 39467731)
17. Alvarez-Buylla A, Lim DA. For the long run: Maintaining germinal niches in the adult brain. Neuron 2004; 41:683-686. (Pubitemid 38326831)
18. Mirzadeh Z, Merkle FT, Soriano-Navarro et al. Neural stem cells confer unique pinwheel architecture to the ventricular surface in neurogenic regions of the adult brain. Cell Stem Cell 2008; 3:265-278.
19. Palmer TD, Willhoite AR, Gage FH. Vascular niche for adult hippocampal neurogenesis. J Comp Neurol 2000; 425:479-494.
20. Shen Q, Wang Y, Kokovay E et al. Adult SVZ stem cells lie in a vascular niche: A quantitative analysis of niche cell-cell interactions. Cell Stem Cell 2008; 3:289-300.
21. Tavazoie M, Van der Veken L, Silva-Vargas V et al. A specialized vascular niche for adult neural stem cells. Cell Stem Cell 2008; 3:279-288.
22. Carmeliet P. Blood vessels and nerves: Common signals, pathways and diseases. Nat Rev Genet 2001; 4:710-720.
23. Calof AL, Mumm JS, Rim PC et al. The neuronal stem cell of the olfactory epithelium. J Neurobiol 1998; 36:190-205. (Pubitemid 28363231)
24. Pardal R, Ortega-Saenz P, Duran R et al. Glia-like stem cells sustain physiologic neurogenesis in the adult mammalian carotid body. Cell 2007; 131:364-377. (Pubitemid 47576136)
25. Kruger GM, Mosher JT, Bixby S et al. Neural crest stem cells persist in the adult gut but undergo changes in self-renewal, neuronal subtype potential, and factor responsiveness. Neuron 2002; 35:657-669. (Pubitemid 35223026)
26. Tomita Y, Matsumura K, Wakamatsu Y et al. Cardiac neural crest cells contribute to the dormant multipotent stem cell in the mammalian heart. J Cell Biol 2005; 170:1135-1146. (Pubitemid 41362645)
27. Doetsch F, Garcia-Verdugo JM, Alvarez-Buylla A. Cellular composition and three-dimensional organization of the subventricular germinal zone in the adult mammalian brain. J Neurosci 1997; 17:5046-5061. (Pubitemid 27263818)
28. Lois C, Alvarez-Buylla A. Long-distance neuronal migration in the adult mammalian brain. Science 1994; 264:1145-1148. (Pubitemid 24210676)
29. Doetsch F, Caille I, Lim DA et al. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 1999; 97:703-716. (Pubitemid 29278045)
30. Arenas E. Engineering a dopaminergic phenotype in stem/precursor cells: Role of Nurr1, glia-derived signals and Wnts. Ann N Y Acad Sci 2005; 1049:51-66. (Pubitemid 40967575)
31. Seri B, Garcia-Verdugo JM, McEwen BS et al. Astrocytes give rise to new neurons in the adult mammalian hippocampus. J Neurosci 2001; 21:7153-7160. (Pubitemid 32846963)
32. Arvidsson A, Collin T, Kirik D et al. Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med 2001; 8:963-970.
33. Kuo CT, Mirzadeh Z, Soriano-Navarro M et al. Postnatal deletion of Numb/Numblike reveals repair and remodeling capacity in the subventricular neurogenic niche. Cell 2006; 127:1253-1264. (Pubitemid 44894526)
34. Schuarting RK, Hustoo JP. The uoilateral 6-hydroxydopamioe lesioo model io behavioral braio research. Analysis of functional deficits, recovery and treatments. Prog Neurobiol 1996; 50:275-33 1.
35. Heikkila RE, Hess A, Duvoisin RC. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice. Science 1984; 224:1451-1453. (Pubitemid 14123348)
36. Li Y, Liu W, Oo TF et al. Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease. Nature Neuroscience 2009; 12:826-828.
37. Pascual A, Hidalgo-Figueroa M, Piruat JI et al. Absolute requirement of GDNF for adult catecholaminergic neuron survival. Nature Neuroscience 2008; 11:755-761. (Pubitemid 351896676)
38. Kirik D, Georgievska B, Bjorklund A. Localized striatal delivery of GDNF as a treatment for Parkinson disease. Nature Neuroscience 2004; 7:105-110. (Pubitemid 38129784)
39. Bjorklund A, Stenevi U. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res 1979; 177:555-560. (Pubitemid 10241286)
40. Perlow MJ, Freed WJ, Hoffer BJ et al. Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science 1979; 204:643-647. (Pubitemid 9221523)
41. Redmond DE, Sladek JR Jr, Roth RH et al. Fetal neuronal grafts in monkeys given methylphenyltetrahydropyridine. Lancet 1986; 1:1125-1127.
42. EreedWJ, Morihisa JM, Spoor E et al. Transplanted adrenal chromaffincells inratbrainreduce lesion-induced rotational behaviour. Nature 1981; 292:351-352. (Pubitemid 11050339)
43. Galpern WR, Burns LH, Deacon TW et al. Xenotransplantation of porcine fetal ventral mesencephalon in a rat model of Parkinson's disease: Functional recovery and graft morphology. Exp Neurol 1996; 140:1-13. (Pubitemid 26266588)
44. Nakao N, Kakishita K, Uematsu Y et al. Enhancement of the response to levodopa therapy after intrastriatal transplantation of autologous sympathetic neurons in patients with Parkinson disease. J Neurosurg 2001; 95:275-284. (Pubitemid 32799750)
45. Espejo EF, Montoro RJ, Armengol JA et al. Cellular and functional recovery of Parkinsonian rats after intrastriatal transplantation of carotid body cell aggregates. Neuron 1998; 20:197-206. (Pubitemid 28125065)
46. Toledo-Aral JJ, Mendez-Ferrer S, Pardal R et al. Trophic restoration of the nigrostriatal dopaminergic pathway in long-term carotid body-grafted parkinsonian rats. J Neurosci 2003; 23:141-148. (Pubitemid 36050413)
47. Luquin MR, Montoro RJ, Guillen J et al. Recovery of chronic parkinsonian monkeys by autotransplants of carotid body cell aggregates into putamen. Neuron 1999; 22:743-750. (Pubitemid 29203497)
48. Villadiego J, Mendez-Ferrer S, Valdes-Sanchez T et al. Selective glial cell line-derived neurotrophic factor production in adult dopaminergic carotid body cells in situ and after intrastriatal transplantation. J Neurosci 2005; 25:4091-4098. (Pubitemid 40563384)
49. Backlund EO, Granberg PO, Hamberger B et al. Transplantation of adrenal medullary tissue to striatum in parkinsonism. First clinical trials. J Neurosurg 1985; 62:169-173. (Pubitemid 15159941)
50. Lindvall O, Rehncrona S, Brundin P et al. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up. Arch Neurol 1989; 46:615-631.
51. Arjona V, Minguez-Castellanos A, Montoro RJ et al. Autotransplantation of human carotid body cell aggregates for treatment of Parkinson's disease. Neurosurgery 2003; 53:321-328; discussion 328-330.
52. Lindvall O, Brundin P, Widner H et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 1990; 247:574-577.
53. Kopyov OV, Jacques DS, Lieberman A et al. Outcome following intrastriatal fetal mesencephalic grafts for Parkinson's patients is directly related to the volume of grafted tissue. Exp Neurol 1997; 146:536-545. (Pubitemid 27381861)
54. Minguez-Castellanos A, Escamilla-Sevilla F, Hotton GR et al. Carotid body autotransplantation in Parkinson disease: A clinical and positron emission tomography study. J Neurol Neurosur Ps 2007; 78:825-831. (Pubitemid 47204586)
55. Kiskiois E, Eggan K. Progress toward the clinical application of patient-specific pluripotent stem cells. 3 Clin Invest 2010; 120:51-59.
56. Lindvall O, Kokaia Z. Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease. Trends Pharmacol Sci 2009; 30:260-267.
57. Perrier AL, Tabar V, Barberi T et al. Derivation of midbrain dopamine neurons from human embryonic stem cells. P Natl Acad Sci U S A 2004; 101:12543-12548. (Pubitemid 39122060)